Registration No. 333-21871
================================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
--------------------
Post-effective
Amendment No. 1 to
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
CADUS PHARMACEUTICAL CORPORATION
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware
--------------------
(State or other jurisdiction of incorporation or organization)
13-3660391
--------------------
(I.R.S. Employer Identification No.)
777 Old Saw Mill River Road, Tarrytown, New York 10591-6705
- --------------------------------------------------------------------------------
(Address of Principal Executive Offices)
Cadus Pharmaceutical Corporation 1993 Stock Option Plan
Cadus Pharmaceutical Corporation 1996 Incentive Plan
Written Compensation Contracts with Certain Employees
Written Compensation Contracts with Non-Employee Directors
Written Compensation Contracts with Certain Consultants
-------------------------------------------------------
(Full Title of the Plan)
Jeremy M. Levin
Cadus Pharmaceutical Corporation
777 Old Saw Mill River Road
Tarrytown, New York 10591-6705
------------------------------
(Name and Address of Agent For Service)
(914) 345-3344
--------------------
(Telephone Number, Including Area Code, of Agent For Service)
Copy to: Salomon R. Sassoon, Esq.
Morrison Cohen Singer & Weinstein, LLP
750 Lexington Avenue
New York, New York 10022
(212) 735-8600
================================================================================
<PAGE>
CALCULATION OF REGISTRATION FEE
<TABLE>
<CAPTION>
================================================================================================================
Title of Securities Amount to be Proposed Maximum Proposed Maximum Amount of
to be Registered Registered Offering Price Per Share Aggregate Offering Price Registration Fee
================================================================================================================
<S> <C> <C> <C> <C>
Common Stock, par
value $0.01 per
share, issuable upon
exercise of options
granted under 1993
Stock Option Plan 589,614 $3.51(1) $2,069,545.14 $627.14
================================================================================================================
Common Stock, par
value $0.01 per
share, issuable upon
exercise of options
and stock
appreciation rights
which may be granted
under 1996 Incentive
Plan 164,470 $15.50(2) $2,549,285 $ 772.51
================================================================================================================
Common Stock, par
value $0.01 per
share, issuable upon
exercise of certain
options granted during
1997 under 1996
Incentive Plan 200,000 $13.375(4) $2,675,000 $810.61
================================================================================================================
Common Stock, par
value $0.01 per
share, issuable upon
exercise of certain
options granted during
1997 under 1996
Incentive Plan 100,000 $20.00(5) $2,000,000 $606.06
================================================================================================================
Common Stock, par
value $0.01 per
share, issuable upon
exercise of options
granted during 1996
under 1996 Incentive
Plan 368,864 $6.625(3) $2,443,724 $740.52
================================================================================================================
Common Stock, par
value $0.01 per
share, issuable upon
exercise of options
granted to Philip N.
Sussman under a
Written Compensation
Contract 33,334 $3.60 $120,002.40 $36.36
================================================================================================================
Common Stock, par
value $0.01 per
share, issuable upon
exercise of options
granted to John
Manfredi under a
Written Compensation
Contract 13,334 $3.60 $48,002.40 $14.55
================================================================================================================
Common Stock, par
value $0.01 per
share, issuable upon
exercise of options
granted to Andrew
Murphy under a
Written Compensation
Contract 13,334 $3.60 $48,002.40 $14.55
================================================================================================================
Common Stock, par
value $0.01 per
share, issuable upon
exercise of options
granted to Jeremy
Paul under a Written
Compensation
Contract 13,334 $3.60 $48,002.40 $14.55
================================================================================================================
Common Stock, par
value $0.01 per
share, issuable upon
exercise of options
granted to Lauren
Silverman under a
Written Compensation
Contract 13,334 $3.60 $48,002.40 $14.55
================================================================================================================
Common Stock, par
value $0.01 per
share, issuable upon
exercise of options
granted to Joshua
Trueheart under a
Written Compensation
Contract 13,334 $3.60 $48,002.40 $14.55
================================================================================================================
Common Stock, par
value $0.01 per
share, issuable upon
exercise of options
granted to James S.
Rielly under a
Written Compensation
Contract 6,667 $3.60 $24,001.20 $ 7.27
================================================================================================================
</TABLE>
<PAGE>
<TABLE>
================================================================================================================
<S> <C> <C> <C> <C>
Common Stock, par
value $0.01 per
share, issuable upon
exercise of options
granted to Thomas F.
Deuel under a
Written Compensation
Contract 6,667 $3.60 $24,001.20 $ 7.27
================================================================================================================
Common Stock, par
value $0.01 per
share, issuable upon
exercise of options
granted to Norman R.
Klinman under a
Written Compensation
Contract 6,667 $3.60 $24,001.20 $ 7.27
================================================================================================================
Common Stock, par
value $0.01 per
share, issuable upon
exercise of options
granted to Elliott
M. Ross under a
Written Compensation
Contract 5,501 $3.60 $19,803.60 $ 6.00
================================================================================================================
Common Stock, par
value $0.01 per
share, issuable upon
exercise of options
granted to Jeremy
Thorner under a
Written Compensation
Contract 6,667 $3.60 $24,001.20 $ 7.27
================================================================================================================
Common Stock, par
value $0.01 per
share, issuable upon
exercise of options
granted to Arnold
Levine under a
Written Compensation
Contract 6,667 $3.60 $24,001.20 $ 7.27
================================================================================================================
Common Stock, par
value $0.01 per
share, issuable upon
exercise of options
granted to John
Ransom under a
Written Compensation
Contract 5,040 $3.60 $18,144 $ 5.50
================================================================================================================
Common Stock, par
value $0.01 per
share, issuable upon
exercise of options
granted to Christine
Klein under a
Written Compensation
Contract 4,667 $3.60 $16,801.20 $ 5.09
================================================================================================================
Common Stock, par
value $0.01 per
share, issuable upon
exercise of options
granted to Suzanne
K. Wakamoto under a
Written Compensation
Contract 2,500 $3.60 $9,000 $ 2.73
================================================================================================================
Common Stock, par
value $0.01 per
share, issuable upon
exercise of options
granted to
Christopher Pleiman
under a Written
Compensation
Contract 1,667 $3.60 $6,001.20 $ 1.82
================================================================================================================
Common Stock, par
value $0.01 per
share, issuable upon
exercise of options
granted to Algis
Anilionis under a
Written Compensation
Contract 1,000 $3.60 $3,600.00 $ 1.09
================================================================================================================
Common Stock, par
value $0.01 per
share, issuable upon
exercise of options
granted to Anupama
K. Nadkarni under a
Written Compensation
Contract 834 $3.60 $3,002.40 $ 0.91
================================================================================================================
</TABLE>
<PAGE>
<TABLE>
================================================================================================================
<S> <C> <C> <C> <C>
Common Stock, par
value $0.01 per
share, issuable upon
exercise of options
granted to Mitchell
Silverstein under a
Written Compensation
Contract 834 $3.60 $3,002.40 $ 0.91
================================================================================================================
Common Stock, par
value $0.01 per
share, issuable upon
exercise of options
granted to Michael
A. Spruyt under a
Written Compensation
Contract 834 $3.60 $3,002.40 $ 0.91
================================================================================================================
Common Stock, par
value $0.01 per
share, issuable upon
exercise of options
granted to David
Fruhling under a
Written Compensation
Contract 250 $3.60 $3,002.40 $ 0.27
================================================================================================================
Common Stock, par
value $0.01 per
share, issuable upon
exercise of options
granted to Theodore
Altman under a
Written Compensation
Contract 12,000 $6.75 $81,000 $24.55
================================================================================================================
Common Stock, par
value $0.01 per
share, issuable upon
exercise of options
granted to Harold
First under a
Written Compensation
Contract 12,000 $6.75 $81,000 $24.55
================================================================================================================
Common Stock, par
value $0.01 per
share, issuable upon
exercise of options
granted to Carl
Icahn under a
Written Compensation
Contract 12,000 $6.75 $81,000 $24.55
================================================================================================================
Common Stock, par
value $0.01 per
share, issuable upon
exercise of options
granted to Peter
Liebert under a
Written Compensation
Contract 12,000 $6.75 $81,000 $24.55
================================================================================================================
Common Stock, par
value $0.01 per
share, issuable upon
exercise of options
granted to Robert
Mitchell under a
Written Compensation
Contract 12,000 $6.75 $81,000 $24.55
================================================================================================================
Common Stock, par
value $0.01 per
share, issuable upon
exercise of options
granted to Mark
Rachesky under a
Written Compensation
Contract 12,000 $6.75 $81,000 $24.55
================================================================================================================
Common Stock, par
value $0.01 per
share, issuable upon
exercise of options
granted to William
Scott under a
Written Compensation
Contract 12,000 $6.75 $81,000 $24.55
================================================================================================================
Common Stock, par
value $0.01 per
share, issuable upon
exercise of options
granted to Jack
Wasserman under a
Written Compensation
Contract 12,000 $6.75 $81,000 $24.55
================================================================================================================
</TABLE>
<PAGE>
<TABLE>
================================================================================================================
<S> <C> <C> <C> <C>
Common Stock, par
value $0.01 per
share, issuable upon
exercise of options
granted to Samuel D.
Waksal under a
Written Compensation
Contract 12,000 $6.75 $81,000 $24.55
================================================================================================================
Common Stock, par
value $0.01 per
share, issuable upon
exercise of options
granted to John C.
Cambier under a
Written Compensation
Contract 166,667 $1.50 $250,000.50 $75.76
================================================================================================================
Common Stock, par
value $0.01 per
share, issuable upon
exercise of options
granted to Gary L.
Johnson, under a
Written Compensation
Contract 166,667 $1.50 $250,000.50 $75.76
================================================================================================================
Common Stock, par
value $0.01 issuable
upon exercise of
options granted to
James R. Broach,
under a Written
Compensation
Contract 141,667 $2.571 $364,225.85 $110.37
================================================================================================================
Total Registration Fee . . . . . . . . . . . . . . $ 4,210.33(6)
================================================================================================================
</TABLE>
- ----------
(1) Calculated at the highest price at which any option granted under the 1993
Stock Option Plan is exercisable.
(2) Estimated in accordance with Rules 457(c) and (h) solely for the purpose
of calculating the registration fee and based upon the average of the high
and low trade prices of the Common Stock of Cadus Pharmaceutical
Corporation as reported by the NASDAQ Stock Market on February 10, 1997.
(3) Calculated at the highest price at which any option granted during the
calendar year 1996 under the 1996 Incentive Plan is exercisable.
(4) Calculated at the price at which such options granted under the 1996
Incentive Plan are exercisable.
(5) Calculated at the price at which such options granted under the 1996
Incentive Plan are exercisable.
(6) A fee of $4,202.75 was paid on February 14, 1997, in connection with the
filing of the registration statement on such date. Accordingly, a fee of
$7.58 is being paid in connection with the filing of this Post-Effective
Amendment No. 1 to said registration statement.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as
amended, the registrant certifies that it has reasonable grounds to believe that
it meets all of the requirements for filing on Form S-8 and has duly caused this
registration statement to be signed on its behalf by the undersigned, thereunto
duly authorized, in the City of Tarrytown, State of New York, on this 10th day
of March, 1997.
CADUS PHARMACEUTICAL CORPORATION
By: s/Jeremy M. Levin
-------------------------------------
Jeremy M. Levin
President and Chief Executive Officer
Pursuant to the requirements of the Securities Act of 1933, as
amended, this registration statement has been signed below by the following
persons in the capacities and on the dates indicated:
Signature Title Date
--------- ----- ----
S/Jeremy M. Levin President and Chief Executive March 10, 1997
- ---------------------- Officer (Principal Executive
Jeremy M. Levin Officer) and Chairman of the
Board of Directors
S/James S. Rielly Director of Finance, Controller, March 10, 1997
- ---------------------- Treasurer and Secretary
James S. Rielly (Principal Financial and
Accounting Officer)
Director March __, 1997
- ----------------------
Carl C. Icahn
Director March __, 1997
- ----------------------
Theodore Altman
Director March __, 1997
- ----------------------
Harold First
* Director March 10, 1997
- ----------------------
Peter Liebert
* Director March 10, 1997
- ----------------------
Robert Mitchell
* Director March 10, 1997
- ----------------------
Lawrence Muschek
Director March __, 1997
- ----------------------
Mark H. Rachesky
* Director March 10, 1997
- ----------------------
Nicole Vitullo
Director March __, 1997
- ----------------------
Samuel D. Waksal
* Director March 10, 1997
- ----------------------
Jack G. Wasserman
s/ Jeremy M. Levin*
- ----------------------
Jeremy M. Levin,
Attorney-in-fact
6